Publikationen, an denen er mitarbeitet Mirian Fernández Alonso (18)

2022

  1. Humoral/Cellular Immune Discordance in Stem Cell Donors: Impact on Cytomegalovirus-Specific Immune Reconstitution after Related Hematopoietic Transplantation

    Transplantation and Cellular Therapy, Vol. 28, Núm. 10, pp. 703.e1-703.e8

  2. Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19

    Chest, Vol. 162, Núm. 5, pp. 1006-1016

2021

  1. HIV-1 diagnosis using dried blood spots from patients in Kinshasa, DRC: a tool to detect misdiagnosis and achieve World Health Organization 2030 targets

    International Journal of Infectious Diseases, Vol. 111, pp. 253-260

  2. Hcv diagnosis and sequencing using dried blood spots from patients in kinshasa (Drc): A tool to achieve who 2030 targets

    Diagnostics, Vol. 11, Núm. 3

  3. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

    EClinicalMedicine, Vol. 32

2019

  1. Non-pigmented rapidly growing mycobacteria smooth and rough colony phenotypes pathogenicity evaluated using in vitro and experimental models

    Pathogens and Disease, Vol. 77, Núm. 5

  2. Utility Of POC Xpert HIV-1 Tests For Detection-Quantification Of Complex HIV Recombinants Using Dried Blood Spots From Kinshasa, D. R. Congo

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern spain, 2010/11 to 2015/16

    Eurosurveillance, Vol. 23, Núm. 2

  2. Reduction in mortality associated with secondary cytomegalovirus prophylaxis after solid organ transplantation

    Transplant Infectious Disease, Vol. 20, Núm. 3

2016

  1. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons

    Vaccine, Vol. 34, Núm. 11, pp. 1350-1357

  2. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season

    Eurosurveillance, Vol. 21, Núm. 22, pp. 1-10

  3. Using NS5B sequencing for hepatitis C virus genotyping reveals discordances with commercial platforms

    PLoS ONE, Vol. 11, Núm. 4

2015

  1. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus

    Human Vaccines and Immunotherapeutics, Vol. 11, Núm. 7, pp. 1626-1633

2014

  1. Household transmission of influenza A(H1N1)pdm09 in the pandemic and post-pandemic seasons

    PLoS ONE, Vol. 9, Núm. 9

  2. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis

    Eurosurveillance, Vol. 19, Núm. 6

2013

  1. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis

    Eurosurveillance, Vol. 18, Núm. 7

2012

  1. Influencia de los tiempos entre el inicio de síntomas, la toma de frotis nasofaríngeo y su procesamiento en laboratorio en la detección de gripe

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 1, pp. 11-14

2011

  1. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: Cohort and case-control study

    Vaccine, Vol. 29, Núm. 35, pp. 5919-5924